Activation of the Innate Immune Response against DENV in Normal Non-Transformed Human Fibroblasts by Bustos-Arriaga, José et al.
Activation of the Innate Immune Response against DENV
in Normal Non-Transformed Human Fibroblasts
Jose ´ Bustos-Arriaga
1, Jazmı ´n Garcı ´a-Machorro
1, Moise ´s Leo ´n-Jua ´rez
1, Julio Garcı ´a-Cordero
1, Leopoldo
Santos-Argumedo
1, Leopoldo Flores-Romo
2, A. Rene ´ Me ´ndez-Cruz
3, Francisco J. Jua ´rez-Delgado
4,
Leticia Cedillo-Barro ´n
1*
1Departamento de Biomedicina Molecular Centro de Investigacio ´n y de Estudios Avanzados, Me ´xico Distrito Federal, Mexico, 2Departamento de Biologı ´a Celular Centro
de Investigacio ´n y de Estudios Avanzados, Me ´xico Distrito Federal, Mexico, 3Laboratorio de Inmunologı ´a UMF de la FES Iztacala Universidad Auto ´noma de Me ´xico,
Tlalnepantla Estado de Me ´xico, Mexico, 4Departamento de Cirugia, Hospital Santa Maria Ticoma ´n, Me ´xico Distrito Federal, Mexico
Abstract
Background: When mosquitoes infected with DENV are feeding, the proboscis must traverse the epidermis several times
(‘‘probing’’) before reaching a blood vessel in the dermis. During this process, the salivary glands release the virus, which is
likely to interact first with cells of the various epidermal and dermal layers, cells which could be physiologically relevant to
DENV infection and replication in humans. However, important questions are whether more abundant non-hematopoietic
cells such as fibroblasts become infected, and whether they play any role in antiviral innate immunity in the very early
stages of infection, or even if they might be used by DENV as primary replication cells.
Methodology/Principal Findings: Fibroblasts freshly released from healthy skin and infected 12 hours after their isolation
show a positive signal for DENV. In addition, when primary skin fibroblast cultures were established and subsequently
infected, we showed DENV-2 antigen-positive intracellular signal at 24 hours and 48 hours post-infection. Moreover, the
fibroblasts showed productive infection in a conventional plaque assay. The skin fibroblasts infected with DENV-2
underwent potent signaling through both TLR3 and RIG- 1, but not Mda5, triggering up-regulation of IFNb, TNFa, defensin 5
(HB5) and b defensin 2 (HbD2). In addition, DENV infected fibroblasts showed increased nuclear translocation of interferon
(IFN) regulatory factor 3 (IRF3), but not interferon regulatory factor 7 (IRF7), when compared with mock-infected fibroblasts.
Conclusions/Significance: In this work, we demonstrated the high susceptibility to DENV infection by primary fibroblasts
from normal human skin, both in situ and in vitro. Our results suggest that these cells may contribute to the pro-
inflammatory and anti-viral microenvironment in the early stages of interaction with DENV-2. Furthermore, the data suggest
that fibroblast may also be used as a primary site of DENV replication and provide viral particles that may contribute to
subsequent viral dissemination.
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Introduction
Dengue virus (DENV) has become one of the most important
arthropod-borne viral infections of humans, with approximately
100 million cases per year. The etiological agent is a positive-sense,
single-stranded RNA virus that belongs to the Flaviviridae family, of
which there are four antigenically related serotypes (DENV-1,
DENV-2, DENV-3 and DENV-4) [1,2].
Cumulative data have demonstrated that both the innate and
adaptive immune responses participate in the control and
pathogenesis of Dengue disease, which has a wide spectrum of
clinical forms ranging from weak Dengue Fever (DF) to severe
dengue disease, such as dengue shock syndrome and hemorrhagic
Dengue (SSD/DHF). A rapid initiation of the innate host defense
may be the critical limiting step in the infection because the
Dengue virus must overcome all barriers mediated by innate
immunity before arriving at the regional lymphoid tissues [3].
The symptoms generally appear 4–7 days afterward; at this
point, when the adaptive immune response may be ongoing, the
patients usually present for medical care. As a result, much work
has been devoted to understanding the adaptive immune response
to DENV, but not enough information has been raised about the
very early steps of interaction with the host [4–6].
One of the most intriguing questions about dengue is the
identity of the non-hematopoietic cells that may play a crucial role
in the innate antiviral immune response to DENV in the early
stages of infection. Given the fact that mosquitoes inoculate
DENV into human skin while they are feeding, the potential target
cells for dengue infection should be localized in the dermis and
epidermis, which constitute the first level of defense [7].
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keratinocytes and fibroblasts. These cells could act either as a
limiting step or like a jumpstart of the replication cycle, depending
on inoculation multiplicity, and intrinsic host variability. Early
studies infecting human forearm dermal fibroblasts have suggested
the participation of skin fibroblasts in the immune response against
DENV [8].
Although dendritic cells and monocytes in the skin have been
suggested as important targets of DENV infection, the number of
these cells is considerable low compared with fibroblasts [9,10].
The skin is not only a physical protective barrier; it also
participates in the rapid initiation of innate host defenses that
might represent a limiting step to DENV infection. In the skin,
both the infiltrating cells (such as macrophages, neutrophils,
dendritic cells and lymphocytes), and the resident cells, such as the
keratinocytes and fibroblasts that are abundantly localized in the
epithelia, participate in the production of various types of
cytokines, establishing a pro-inflammatory microenvironment with
antimicrobial activity against arthropod borne pathogens such as
enveloped viruses [11]. Although some of these elements have
been exhaustively reviewed by Nielsen et al. [12], little is known
about the events that occur in the skin in the very early stages after
mosquito feeding.
It is conceivable that DENV has evolved mechanisms to evade
the early innate host responses, which are initiated by pattern
recognition receptors (PRRs). Among the PRRs the family of
membrane–bound Toll-like receptors (TLRs) [13] and the RIG-I
like receptors (RLR); Retinoic acid-inducible gene (RIG-I) and the
melanoma differentiation-associated gene 5 (Mda5) [14]. PRRs
triggering lead to a signaling cascade that converges on the
activation of latent transcription factors, such as interferon
response factor 3 (IRF3), interferon response factor 7 (IRF7) and
nuclear factor kB (NF-kB) activating transcription factor 2 (ATF-
2)/c-Jun. The transcription factors undergo subsequent nuclear
translocation and bind to the type I interferon’s (IFNa/b) gene
promoters. Then activated homo- and hetero-dimers of IRF3 and
IRF7 bind to the IFN-stimulated response elements (ISRE) located
in the promoter regions of various ISGs, including ISG54, ISG56
and ISG15, thereby enabling direct IFN-independent activation of
these ISGs. The synthesis of type 1 IFNs, in turn leads to the
development of an antiviral state in the surrounding cells and to
the activation and modulation of the adaptive immune system
[15–17].
Cumulative data have shown that DENV is sensed by both
TLR3 and TLR7. At this respect Warke et al., demonstrated that
plasmacitoid dendritic cells (pDCs) constitutively express both
TLR7 and through IRF7 lead to IFNa/b production in response
to DENV. By contrast, HUVEC cells or U937 cells that have
internalized DENV produce IL-8 and IFNa/b after viral
recognition through TLR3 [18–20].
Cytoplasmic molecules, such as RIG-I (which senses short
double-stranded blunt-end 59-triphosphate RNA) and MDA5
(which recognizes long dsRNA), have been shown to play an
important role in sensing different flavivirus, including DENV.
Recent experiments using single and double RIG-I/MDA5
knockout, fibroblast cell lines have shown that DENV triggers
the interaction of both molecules with the IPS-1 molecule to
activate IRF3, IkB kinase and phosphatidylinositol-3 kinase (PI3K)
[21,22]. In addition, Conceicaoi et al., showed that TLR3, TLR8,
RIG-I and MDA5 mRNA are up-regulated, along with the type I
interferon IFNb and pro-inflammatory cytokines, in HepG2 cells
infected with DENV [23].
The IFN response is one of the early mechanisms of host
defense that contributes significantly to innate immunity. The IFN
system includes cells that synthesize IFN in response to viral
infection. The induction of IFNa or b is one of the early events
that follows viral infection, and it is widely accepted as the most
immediate and important antiviral host response to many viral
infections [24].
Indeed, mice deficient in IFNa/b and IFNc receptors are more
susceptible to mortality following intraperitoneal inoculation of
mouse-adapted DENV [25,26]. A strong IFNa-mediated inhibi-
tory effect on DENV replication was also observed when different
cell types were treated with IFNb prior to virus exposure [27].
Recently, antimicrobial peptides have been considered as a key
element in the defense mechanisms of the skin. Cumulative data
had shown that defensins modulate the immune response against
both enveloped and non-enveloped virus, by inducing cytokine
and chemokine production and inflammatory and immune cell
activation [28,29]. In this study, we demonstrated that skin
fibroblasts freshly released from healthy human skin and
subsequently infected with DENV showed positive viral antigen
at 48 h post-infection.
Considering that fibroblasts are one of the most abundant
dermal cells in the host during early contacts with this virus,
primary skin fibroblast cultures were established to address the
contribution of these cells in innate immunity. Our findings
revealed that fibroblasts sense the DENV through TLR3 and
RIGI which then signal to produce IFNb, TNF, and b defensins.
We believe these are previously unrecognized features of
importance in the immunobiology of DENV infection.
Materials and Methods
Cells and DENV-2 virus
The DENV-2 clinical isolate that we used has been described
previously [5]. Mosquito C6/36 cells derived from Aedes albopictus
were grown in MEM supplemented with 10% fetal bovine Serum
(FBS) (Gibco Carlsbad, CA) at 34uC. Baby hamster kidney (BHK-
21) cells were cultured at 37uC in the presence of 5% CO2 in
MEM supplemented with 10% FBS, 1 IU penicillin/mL, 1 mg/
mL streptomycin and 2.4 ng/mL of amphotericin B at final pH of
Author Summary
In this work, we demonstrate that that both human whole
skin and freshly isolated skin fibroblasts are productively
infected with Dengue virus (DENV). In addition, primary
skin fibroblast cultures were established and subsequently
infected with DENV-2; we showed in these cells the
presence of the viral antigen NS3, and we found
productive viral infection by a conventional plaque assay.
Of note, the infectivity rate was almost the same in all the
primary cultures analyzed from different donors. The skin
fibroblasts infected with DENV-2 underwent signaling
through both TLR3 and RIG-1, but not Mda5, triggering
up-regulation of IFNb, TNFa, defensin 5 (HB5) and b
defensin 2 (HbD2). In addition, DENV infected fibroblasts
showed increased nuclear translocation of interferon (IFN)
regulatory factor 3 (IRF3), but not interferon regulatory
factor 7 IRF7, when compared with mock-infected
fibroblasts. Our data suggest that fibroblasts might even
participate producing mediators involved in innate immu-
nity that activate and contribute to the orchestration of
the local innate responses. This work is the first evaluating
primary skin fibroblast cultures obtained from different
humans, assessing both their susceptibility to DENV
infection as well as their ability to produce molecules
crucial for innate immunity.
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monolayer in 75 cm
2 tissue culture flasks at 75%–85% confluence.
When the infected monolayer showed cytopathic effects, the cells
and supernatant were homogenized and diluted in a 40%
polyethylene glycol solution in 2 M NaCl (Sigma-Aldrich St.
Louis, MO) and incubated at 4uC overnight. The suspension was
centrifuged at 6000 rpm for 1 h. The virus was resuspended in 1/
15 of the total volume with a glycine buffer (Tris 50 mM, Glycine
200 mM, NaCl 100 mM and EDTA 1 mM) and 1/30 of the total
volume of FBS. The virus was homogenized, aliquoted and frozen
at 270uC until use.
The virus was titrated by the standard plaque-forming assay
technique using BHK-21 cells as described elsewhere. Briefly, ten-
fold serial dilutions of virus stock in Hank’s salt solution (Gibco
Carlsbad, CA) were used to infect monolayers of BHK-21 cells in
24-well plates. After incubation at 37uC for 1 h, the infected cells
were overlaid with MEM Eagle modified medium (Gibco
Carlsbad, CA) with 3% carboxymethyl cellulose (Sigma-Aldrich
St. Louis, MO). After 5 days, the resulting plaques were stained
with naphthol blue-black solution to quantify the plaque forming
units (PFUs).
Immunohistology
Freshly prepared, non-cadaveric, healthy human skin was
obtained at the Surgery Department of the Hospital General de
Ticoman (the protocol was approved by the hospital ethical
committee) from patients submitted to general surgery; the tissue
was obtained from the wound area during the surgical procedure.
For the histology, the biopsies were washed extensively with
Dulbecco containing penicillin (200 mg/mL) and streptomycin
(200 U/ml) as described by Limon-Flores et al [5]. The tissue was
then cut into pieces of approximately 1.0 cm
2, the underlying fat
was carefully removed and each piece was placed (epidermis side
up) into individual wells in a 12-well culture plate (Costar corning,
NY, USA). Skin explants were gently inoculated with 1610
6 PFU
of the virus in a total volume of 30 mL using a 30-gauge insulin
syringe needle (HSW, Tuttlingen, Germany) in the upper side of
the epidermis, causing penetration into the dermis without passing
through the explants. Control explants were inoculated with either
UV-inactivated DENV or with PBS for the manipulation control.
The inoculated explants were incubated in a 24-well plate for 24
and 48 h with DMEM containing 15% FBS and supplemented
with antibiotic, antimycotic, non-essential amino acids and L-
glutamine (Gibco Carlsbad, CA) in an incubator with a humid
atmosphere and 5% CO2 at 37uC. At the end of the incubation,
the skin was mounted in tissue freezing medium (Jung 0201
08926). The histological sections were obtained as described
elsewhere [5].
Tissue immunofluorescence
The explants where cut into 10 mm frozen sections. The tissue
sections were fixed with 4% paraformaldehyde (Sigma-Aldrich St.
Louis, MO) for 1 h. After 4 washes with PBA, the sections were
blocked with goat serum at 10% in PBA for 1 h. The primary and
secondary antibodies were incubated for 1 h. After 5 washes
between each antibody, the samples were mounted and analyzed
using a confocal microscope (Olympus FXM).
Cell suspension from fresh skin and immunofluorescence
The fat tissue was removed carefully from the normal skin
explants with a scalpel. The tissue was then cut into pieces of
approximately 1 mm
2 and washed exhaustively with DPBS
(Sigma-Aldrich St. Louis, MO) supplemented with an antibiotic
solution (3 IU/mL of penicillin, 3 mg/mL of streptomycin and
7.2 ng/mL of amphotericin B). Afterward, the tissue was
incubated with a collagenase/dispase cocktail at 37uC in agitation.
The cells in suspension were collected at 12 h and 24 h post-
treatment. All cells were split into two 24-well plates over a slide
treated with poly L-Lysine. They were then incubated for 12 h at
37uC in a 5% CO2 atmosphere. The cells were infected with
1610
6 PFU of the virus and the immunofluorescence was
performed as described below. The cells were double-stained for
fibroblasts (Sigma-Aldrich St. Louis, MO) and for the dengue
envelope protein (Chemicon Millipore Billerica, MA). Mouse anti-
human IgM-rhodamine (Jackson Pennsylvania, Phi), and goat anti
mouse IgG2a-FITC (Southern Biotech Birmingham, AL) were
used as the secondary antibodies.
Establishment of primary cultures of fibroblasts from
human skin explants
The explants where cut into pieces of approximately 2 mm
2,
and the tissue were incubated for 4.5 hours in a cocktail of
collagenase and dispase (0.5 U/mL and 4 U/mL, respectively).
After this treatment, the epidermis was mechanically removed
from the dermis and incubated separately in a 0.1% trypsin
solution (Sigma-Aldrich St. Louis, MO) for 30 minutes. The cell
suspension and tissue fragments were then resuspended in DMEM
medium (Gibco Carlsbad, CA) containing 20% fetal calf serum
(FCS) and 10 ng/mL epidermal growth factor (Gibco Carlsbad,
CA) in a 25-cm
2 flask. After incubation for 5 to 10 days, when
adherent cells covered the plastic flask, the tissue was removed and
the cells were maintained in DMEM medium (Gibco Carlsbad,
CA) containing 15% FCS and 10 ng/mL epidermal growth factor
(Gibco Carlsbad, CA). The culture was passaged until confluence
was reached. In addition, surface fibroblast protein marker
expression was checked for each established primary culture.
The cultures were used between the passages 2–10.
Flow cytometry staining
Infection of the skin fibroblasts was analyzed by flow cytometry.
Briefly, 2610
5 primary human skin fibroblasts were infected with
5 PFU/cell of DENV-2. Six hours before harvesting, the cells
were treated with brefeldin A (Sigma-Aldrich St. Louis, MO) to
interrupt the vesicular traffic. After 3 washes, the cells were fixed
and treated with a permeabilizing solution (Becton Dickinson,
Franklin Lakes, N.J) for 45 minutes. The cells were analyzed at 6,
12, 24 and 48 hours post-infection. All the cells were treated for
30 minutes with a non-related immunoglobulin solution (10%
goat serum in PBS) to block the Fc receptors. The primary
antibodies were diluted in blocking solution (PBS-10% Goat
serum) at the corresponding dilutions: E protein (Chemicon
Millipore Billerica, MA), IFNb (Santa Cruz CA, USA), APC-
TNFa (Serotec Kidlington UK), human b defensin 2 (Santa Cruz
CA, USA), human defensin 5 (Santa Cruz, CA, USA), TLR3
(ebiosciences San Diego, CA), RIG-I (Santa Cruz CA, USA),
Mda5 (Santa Cruz CA, USA) and fibroblasts surface protein
(Sigma-Aldrich St. Louis, MO). The non-conjugated antibodies
were marked with the corresponding secondary antibodies: anti-
mouse IgG H+L (Caltag Invitrogen Carlsbad CA), sheep IgG H+L
(Invitrogen, Carlsbad CA), anti-rabbit IgG H+L (Invitrogen,
Carlsbad CA), and anti- goat IgG H+L Zymed Invitrogen
Carlsbad CA). For flow cytometry, the cells were resuspended in
0.01% EDTA in PBS. Data were collected using a FACS Calibur
flow cytometer (Becton Dickinson, Franklin Lakes, N.J) and
analyzed using FlowJo software (Tree Star, Inc.). All the results
were statistically analyzed using t student test with graph pad
Prism 5 software (CA, USA).
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Total RNA was extracted at the indicated times from mock- or
DENV-infected cells Poly I:C (Amershan USA) transfected cells
(as positive control) using TRIZOL reagent (Gibco Carlsbad, CA),
according to the manufacturer’s instructions. The RNA concen-
tration was measured by spectrophotometry, and the quality of the
purified RNA was analyzed. Total RNA (2 mg) was used for
DNase (Invitrogen, Carlsbad CA) digestion, and RT for the
synthesis of the first strand of cDNA was performed using
SUPERSCRIPT (Invitrogen, Carlsbad CA) in a final volume of
30 ml. Five percent of the first-strand reaction was used for the
PCR analysis. The PCR amplification was performed using
specific primers for RIG-I (59 GCATATTGACTGGACGT-
GGCA-39 and 59 CAGTCATGGCTGCAGTCC TGTC-39),
TLR3 (59-CCCTTGCCTCACTCCCC-39 and 59-CCTCTCCA-
TTCCTGG CCT-39), TLR7 (59-CCTCAGCCACAACCAACT-
G-39 and 59-TTGTGTGCTCCTG GCCCC-39) and GAPDH
(59-GACCCCTTCATTGACCTCAAC-39 and 59-GTCCATG-
CCCATCA CTGCCAC-39). The PCR products were separated
by 1% agarose gel electrophoresis. The assays were performed at
least three times from different RNA preparations.
Immunofluorescence of cell cultures
The cells were seeded on glass cover slips (6610
4) (Bellco NJ
USA). After 24 h, the culture medium was removed and
monolayers were infected with DENV-2 active or UV-inactivated
virus both at 5 PFU per cell; they were then incubated at 37uC
and analyzed by immunofluorescence at different times. Briefly,
the cells were fixed with 4% para-formaldehyde (Sigma-Aldrich St.
Louis, MO) in PBS for 20 minutes at room temperature; the cells
were then permeabilized with 0.1% Triton-6100 in PBS and
blocked with 10% normal goat serum. The cell monolayer was
treated for 60 minutes with primary antibody: E protein
(Chemicon Millipore Billerica, MA), NS3 [30], NFkB p50 (Novus
Biologicals), IRF3 (Santa Cruz CA, USA), IRF3 ser396 (Cell
Signaling 4D46 4947S), IRF7 (Santa Cruz CA, USA) and
fibroblasts surface protein (Sigma-Aldrich St. Louis, MO) followed
by fluorochome-conjugated secondary antibody mouse IgG H+L
(Caltag Invitrogen Carlsbad CA), rabbit (Invitrogen, Carlsbad
CA), and goat (Zymed Invitrogen Carlsbad CA). An irrelevant
isotype antibody that matched the monoclonal antibody was used
as a negative control.
Finally the nucleus was labeled with DAPI (1 mg/mL) in PBS for
10 minutes and the slides were mounted with Vectashield
(Vector). The images were captured using two different confocal
microscopes (Leica SP2 and OLYMPUS FVX).
ELISA assay to detect IFNb in primary fibroblast cultures
Primary skin fibroblasts were seeded and infected at 5 MOI as
described previously. The supernatants were harvested at 12 h
post-infection for IFNb (Interferon source, NJ USA) and at 24 h
for TNFa (Biolegend NJ USA). The cytokine levels were measured
according to the manufacturer’s instructions. Absorbance at
450 nm was measured using the ELISA reading equipment
(Sunrise Tecan, Salzburg, Austria).
Terminal deoxynucleotidyltransferase-mediated dUTP
nick-end labeling (TUNEL) assay
Apoptosis-induced DNA strand breaks were end-labeled with
dUTP terminal deoxynucleotidyltransferase using a commercial
kit, according to the manufacturer’s instructions (In Situ Cell Death
Detection kit, TMR red; Roche Indianapolis, IN) Briefly, the cells
were fixed with para-formaldehyde [2% in phosphate-buffered
saline (pH 7.4)] for 60 min at room temperature and permeabi-
lized in 0.1% Triton X-100–0.1% sodium citrate for 2 min in an
ice bath. The TUNEL reaction was performed using TMR red
dUTP at 37uC for 60 min, and the labeling was analyzed by
fluorescent microscopy. TUNEL assays with infected and mock-
infected cells with different DENV 2 proteins were performed at
24 and 48 h post-infection. As a positive control, human primary
cultured skin fibroblasts were exposed to 10 mg/mL DNase for
10 min at room temperature.
Results
DENV is present in human skin explants inoculated with
DENV-2
To investigate whether healthy human fibroblasts from the skin
are infected in situ with DENV-2, we employed a model previously
reported by our group using non-cadaveric fresh skin explants [5].
The tissue samples were either infected with 1610
6 DENV-2 or
mock-infected, and 24 hours later analyzed by immunofluores-
cence. The DENV-2-infected tissue showed cells with viral antigen
(E protein in green) in the dermis area; these cells were likely
dermal fibroblasts due to their morphology and location. By
contrast, no expression of E protein was detected in skin explants
incubated with the UV-inactivated virus (mock 48 h), as shown in
Figure 1A.
To verify this result, healthy human skin was processed as
described in Materials and Methods to obtain fresh skin cell
suspensions. These cells were incubated for 12 hours before
infection to allow the re-expression of cell receptors that might
have been lost during the colagenase/dispase treatment. The Skin
cell suspensions were then infected with 1610
6 PFUs and
analyzed 48 h post infection. Skin fibroblast infection was assessed
by immune detection of E protein (green); the monoclonal
antibody 1B10, which is specific for a fibroblast surface protein,
was used to identify fibroblasts (red). Figure 1B clearly shows that
the fibroblasts from healthy skin are permissive to DENV-2
infection; in contrast to mock-infected dermal suspensions, where
only the fibroblast marker (red) was observed. Of note, 7% of
infected cell suspension that were positive for fibroblast marker,
also showed a positive labeling for DENV antigen E, Thus
corroborating the above results in which we also detected viral
antigens in the in situ zone where fibroblasts are located Figure 1C.
These data warranted further investigation regarding fibroblasts,
as these may be one of the cell types that first support dengue virus
and other flavivirus infections in vivo after the bite of flavivirus-
infected mosquitoes.
Establishment of primary skin fibroblasts cultures
It is well known that established immortalized cell lines may
have multiple mutations that can affect the permissiveness to viral
infections [31,32]. In addition, fibroblasts are one of the more
abundant cell types in the skin where the mosquito introduces the
DENV. Thus, primary skin fibroblast cultures should be an
appropriate in vitro model to provide insights about the role of if
these cells in skin.
We established 10 primary cultures of skin fibroblasts from 10
different donors who were free from any known infectious disease
and especially had no dermatological disorders. Skin biopsies were
obtained from these donors who consented to participate in this
study. The characteristics of the surgery, age, and the permissive-
ness of DENV infection as well as general information about the
donors are included in the Figure S1A.
Each cell culture was first characterized by flow cytometry,
assessing the expression of fibroblasts cell surface protein marker
Skin and Innate Immunity
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cultures of established skin fibroblasts consisted of a homogeneous
population of cells expressing the protein marker recognized by
1B10 antibody. HMEC-1 cells (endothelial cells) and isotype
control staining were used as the corresponding controls. All the
experiments were carried out on fibroblasts with less than 10
passages, because according with our data after more than 15
passages the cells become highly permissive to DENV infection,
indicating changes regarding the original cells. Our data show that
infection of primary skin fibroblasts from passages 2–14 did not
exhibit overt changes in the percentage of infection (data no
shown).
Once the primary cultures were established and well
characterized, they were infected with DENV-2 at MOI of 5.
The cells were then harvested and the expression of E protein was
analyzed by flow cytometry at different post-infection times. To
address whether the origin of the subjects skin biopsy may have
influenced the susceptibility of the fibroblasts to infection with
DENV, ten different primary cultures obtained from ten different
subjects were infected or mock-infected, and the data are shown
in the Figure S1C. Figure 2A shows the FACS results of 4
representative infected primary cultures of dermal fibroblasts
expressing the DENV viral E protein with data from 3
independent experiments. The graphics corresponding to the
rest of the cultures are shown in the Figure S1C; according to the
number of viral E protein antigen-positive cells, the range of
infection fluctuates from 21.4% to 31.7% regardless of the donor
source. No E protein expression was detected in the mock-
infected cells (Figure 2A). To further investigate whether the
DENV replicated in the primary fibroblasts, different cultures
were infected or mock-infected and then analyzed by immuno-
fluorescence using a mouse monoclonal antibody to the NS3
protein [30]. Figure 2B shows that only the fibroblasts inoculated
with active DENV-2 showed positive staining for NS3. By
contrast, no staining was observed in the mock-infected cells or
the isotype control cells. Furthermore, a plaque assay was
performed to demonstrate that the fibroblasts supported active
DENV viral replication.
Previous works have shown variation in the susceptibility to
infection among cell types, using different DENV-2 strains. While
some cells are susceptible to infection by all DENV2 strains
assayed, human foreskin fibroblasts showed differences in the
susceptibility to the prototype viral Thai isolates and Nicaraguan
strains, depending on the passage [33]. In order to address this
point we additionally infected four different established skin
fibroblasts with a reference type virus (DEN4 H241). There were
no significant differences in the viral titers obtained from different
fibroblast cultures, and each line showed similar viral replication
kinetics regardless of the donor (Figure 2C).
The results presented here strongly support the notion that skin
fibroblasts must be one of the primary cell types that can hold up
initial dengue virus infections in situ, during or immediately after
the bite of a DENV-2-infected mosquito.
PRR(s) are involved in the fibroblasts detection of DENV
Previous reports have demonstrated that the TLR3 and TLR7
molecules are involved in flavivirus recognition. These molecules
are predominantly observed in the intracellular compartments.
Meanwhile, RIG-I and MDA5 are cytoplasmic sensors involved in
the recognition of RNA. Furthermore, the above mentioned
Figure 1. Infection of normal skin cells by the Dengue virus. A) Skin explants were inoculated (with 1610
6 PFU in a total volume of 30 mL)
with a 30-gauge insulin syringe needle from the epidermis side. After 48 h of incubation, sections of 10 mm were stained for the presence of E
glycoprotein (green) in mock-infected (Mock) and, DENV-2 infected skin primary fibroblasts. B) Human skin cells were obtained from fresh skin
explants. The cells in the suspension were collected at 24 h after the enzymatic treatment. Afterwards, the suspension was left in complete culture
medium for 12 h to allow for the recovery of receptors, the cells were then infected (DENV), or mock infected with 1610
6 PFU of the DENV. After 48 h
double staining was performed for the presence of envelope protein (green fluorescence) and Fibroblast protein (red fluorescence). The nucleus was
contrasted with DAPI (blue fluorescence) C) Quantitation of DENV infected fibroblasts cells was determined by microscopic analysis. Two hundred
cells from each experiment were counted on three different fields of cells suspension. Four different cells suspension were analyzed.
doi:10.1371/journal.pntd.0001420.g001
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immunity against DENV-2 in a mouse embryonic fibroblast
model [22]. However, the variation among virus strains/serotypes
or cell types may suggest distinct cellular responses. Furthermore
in this study, we addressed whether human primary skin
fibroblasts sense DENV through different PRRs than have been
reported for different cell lineage, including MEFs.
Semi-quantitative RT-PCR analysis was performed in DENV-
infected fibroblasts (Figure 3A). The mRNA levels of both TLR3,
and RIG I showed changes at 18 hr post-infection and
densitometry analysis was performed on these data. The results
suggest that both TLR3 and RIG signaling are required for
activating of innate response and for establishing an antiviral state
in skin fibroblasts in response to DENV-2 infection. To verify the
RT-PCR results, a flow cytometry assay was performed in DENV
infected primary skin fibroblasts. We confirmed RIG-I up-
regulation in skin fibroblasts at 12 h post-infection with a
maximum at 36 h post infection, whereas there were no significant
changes in RIG, TLR3 and Mda5 expression in the mock-infected
cells or the non-treated cells (Figure 3D, C, D). By contrast,
changes in the infected cells regarding expression of TLR3
molecule were observed as early as 6 h post-infection, with the
maximum level occurring at 12 hours post-infection. Subsequent-
ly, both RIG-I and TLR3 protein levels were stabilized, and no
important changes were observed in the Mda5 molecule. Our
results suggest that both RIG-I and TLR3 may act in concert to
detect DENV RNA in primary skin fibroblasts cultures (Figure 3D
and 3B).
Dengue infection induces IFNb in primary human
fibroblasts
In keeping with the other evidence presented in this article that
a fresh skin fibroblast primary culture is highly permissive to
active infection with DEN-2 virus, we evaluated the ability of
DENV-2 to elicit a functional antiviral response. The induction
of type I interferon (IFNa/b) is an early protective event that
occurs within hours of viral infection and is widely accepted as
one of the most immediate and important antiviral host response
[34]; therefore, we investigated whether human skin fibroblasts
produce IFNb upon infection with DENV-2. A flow cytometry
assay was performed, and Figure 4A shows primary skin
fibroblasts from four different donors (D1, D2, D3 and D4);
three independent experiments were performed with each culture
and the results are presented as the mean fluorescence intensity
(MFI). Figure 4A clearly shows differences among the donors.
However, all primary cultures analyzed consistently showed that
the infected fibroblasts expressed significant levels of IFNb within
6–12 h of infection (Figure 4A); the expression decreased at 24 h
in inverse proportion to the amount of virus. Indeed, in some of
the primary cultures, the MFI of the IFNb produced by infected
fibroblasts (50 MFI) was higher than that of the IFNb produced
by poly I:C-stimulated cells (20 MFI), used as a positive control.
These results contrast to the low levels observed in the uninfected
and mock-infected cells.
Furthermore, we analyzed the levels of IFNb in the culture
supernatants of primary skin fibroblasts of four donors (D1–4)
(Figure 4B), and we found that the cells of D2 and D4 donors
Figure 2. Skin fibroblasts from different donors are permissive to DENV-2 infection and replication. A) FACS analysis to assess the
permissiveness of four representative primary skin fibroblasts from different donors (D1–4) infected with DENV at 5 MOIs. E protein expression was
analyzed at 48 h post-infection using a specific monoclonal antibody. The percentage of positive cells is given for each condition, for mock-infected
(Mock) and, DENV-2 infected, primary skin fibroblasts. B) Primary skin fibroblasts were infected and mock-infected with DENV-2 or DENV-4 (H241) at
MOI 5, and immunofluorescence staining was performed to detect NS3 at 48 h post-infection (red). The nuclei were stained with DAPI (blue). C) Skin
fibroblasts from four healthy donors (D1–4) were infected with DENV-2 and DENV-4 at MOI 5 and analyzed at 12, 24, 48, 72 and 96 h post-infection for
DENV virus yields by titrating infectious viral progeny on permissive BHK cells. Each line represents a different donor.
doi:10.1371/journal.pntd.0001420.g002
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partially corroborated the cytometry results. Although, all of the
skin fibroblasts showed similar IFNb expression kinetics, the total
population was displaced in the histograms, showing a clear
paracrine effect because not all the cells were infected with DENV.
There were clear differences in the magnitude of the response,
although the susceptibility to infection was almost the same in
different fibroblast cultures.
Dengue virus induces TNFa in primary cultures of human
skin fibroblasts
TNFa has been shown to induce inflammation and apoptosis,
thereby limiting viral infection, through a wide variety of
mechanisms. Indeed, TNFa can have a direct effect on viral
tropism by altering the expression of the cell surface receptors used
by viruses; and depletion of this cytokine using TNFa blockers
might facilitate the development or reactivation of the viral
infection [35–37]. Thus, we evaluated the expression of TNFa by
the fibroblasts at various times after infection. Figure 5A shows the
results of two representative primary cell cultures analyzed by flow
cytometry; the results are presented as MFI. The fibroblasts
expressed significant levels of TNFa 24 h post infection. In
contrast, cells treated with UV-inactivated DENV-2 (mock-
infected) and uninfected cells did not show any changes. Similar
trends were seen in all cell lines.
Human skin fibroblasts release defensins upon infection
with DENV-2
Antimicrobial peptides have been demonstrated to be an
important early element of innate immunity. Emerging studies
indicated that certain defensins can block viral infections. Thus,
we decided to investigate whether human primary fibroblasts were
able to produce defensins during DENV infection. The production
of defensins was evaluated at different times post-infection. The
infected cells were able to produce HbD2 as early as 12 h post
infection, reaching maximum production at 24 h (Figure 5B).
DENV-2 infection also induced the production of HD5 at 24 h;
however, the MFI was about half of the corresponding value for
HbD2 (Figure 5C).
Dengue infection induces early nuclear translocation of
IRF3 but not IRF7 in primary human fibroblasts
The transcriptional activation of innate immunity molecules is
dependent on the activation of a family of transcriptional factors
from the NFkB and IRF families. Although IRF3 is ubiquitously
expressed in most cell types, the expression of IRF7 is differentially
regulated, depending upon both the pathogen and host cells.
Because IFNb was produced by skin fibroblasts in response to
dengue infection, we decided to assess the regulatory mechanisms
of this IFN induction. Our first step was to evaluate the role of the
master transcriptional factors IRF3 and IRF7.
Figure 3. The pattern recognition receptors for viral RNA are up regulated by the dengue infection of skin fibroblasts. A) Specific
amplicons corresponding to RIG-I TLR3 and TLR7 were assessed in DENV infected skin fibroblasts from different donors at 5 MOI. At 18 h post
infection the cDNA was synthesized from mRNAs. Results were analyzed using the program Image J 1.410/Java 1.6.0 software and expressed in
relative units for mock-infected (M), DENV-2 infected, uninfected (NI) and Poly I:C transfected primary skin fibroblasts (the control assay) (PIC). Three
different donors were analyzed to evaluate, by flow cytometry, the skin fibroblasts expression level of the corresponding proteins TLR3, B) Mda5, C)
and RIG-I D) for mock-infected (Mock), DENV-2 (infected at 5-MOI), uninfected (NI) and Poly I:C transfected (PIC). Bars represent standard errors for the
four independent experiments from a representative donor.
doi:10.1371/journal.pntd.0001420.g003
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DENV-2. Cellular localization of IRF3 and IRF7 was analyzed by
immunofluorescence at different times post-infection. Figure 6A and
6B show that fibroblasts undergo nuclear accumulation of IRF3
following infection with DENV-2. While in mock and uninfected cells,
IRF3 distribution was predominantly cytoplasmic. By contrast, DENV
infection of skin fibroblasts failed to induce IRF7 nuclear translocation
at 24 or 48 h post-infection (Figure 6E), the location of the molecule
was mainly cytoplasmic. At 72 h, when some changes were detected,
the cells were already damaged and highly granular (Figure 6D).
According with the data described above IRF-3 is likely activated
since 12 h post-infection. However IRF3 has to be phosphorylated to
dimerise before translocating into the nucleus. To asses this,
immunofluorescence was performed again with an anti-IRF3 antibody
to detect active associated phosphorylation (SER 396). Nuclear IRF3
was observed mainly in the infected cells as early as 6 h post-infection
increasing at 24 h post-infection, contrasting with the mock-infected or
the uninfected cells where no nuclear signal was observed (Figure 6C).
Dengue infection induces early nuclear translocation of
p50 in primary human fibroblasts
Activation of the NFkB transcription factors are one of the early
steps during viral infections, the activation of the pathways
involving the homo and hetero-dimmers of p50 have implications
on induction of a pro-inflammatory set of genes and in the
regulation of the inflammatory response [38]. To evaluate if the
infection with DENV induces transcriptional activation of the pro-
inflammatory transcription factor, we evaluated the localization of
p50 by IF in infected cells. At 48 h post-infection, p50 was
observed in the nucleus of both infected and in neighbor cells with
no evident infection, suggesting once again a paracrine effect as
consequence of the antiviral/pro inflammatory micro environ-
ment by the infected fibroblasts. Figure 6F.
DENV-2 clinical isolate induce apoptosis in human skin
fibroblasts
Some viruses direct the apoptosis of infected cells. The
induction of apoptosis may be a viral strategy to aid dissemination.
Furthermore, apoptosis has recently been associated with the
activation of innate immunity pathways in DENV disease via
TRADD caspase activation [39]. To evaluate whether Dengue
virus serotype 2 is able to induce apoptosis in human primary
fibroblast cultures, we infected primary skin fibroblasts with 5
MOI of DENV and then analyzed them at different times.
Twenty-four hours after infection, 34% of the 60% of skin primary
fibroblasts that expressed viral NS3 protein, showed a TUNEL-
Figure 4. Variability in IFNb protein production within donors after mock- or DENV-infection of primary skin fibroblasts. A) mean
fluorescence intensity corresponding to the intracellular staining for IFNb expressed by four different primary cultures obtained from different donors
B) IFNb protein levels were measured at 12 h by a specific ELISA in supernatants at 12 h from mock-infected (Mock), DENV-2 (infected 5MOI),
uninfected (NI) and Poly I:C transfected (PIC) primary skin fibroblasts. Error bars indicate the standard deviations for the three independent
experiments from the four representative donors.
doi:10.1371/journal.pntd.0001420.g004
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maximum infected cell count (68% of the antigen-positive cells)
was reached at 48 h after infection. Mock-infected cells do not
shown viral antigen (NS3).
Discussion
Cumulative invaluable data has been generated regarding the
adaptive immune response against Dengue, focusing in charac-
terizing the most important changes during the disease, such as
those involving antibodies, T cells and cytokines [40,41].
However, insufficient information is available regarding the early
events of the innate immune response when the virus is introduced
through the skin, the natural route to acquire the infection.
Given that mosquitoes inoculate DENV-2 into human skin
while they are feeding, some research have suggested that DENV
initial replication should occur in the skin and that potential target
cells for dengue infection should be the cutaneous DCs localized in
the epidermal and the dermal layers. [5,9,42] Recent evidences
suggest that Langerhans and/or dendritic cells may take up
antigens for processing and presenting them to the adaptive
immune system, instead of working as reservoir cells for the
dengue virus [43,44].
Clearly other non-hematopoyetical cutaneous cells may poten-
tially be infected; fibroblasts are one of the most abundant cell
types at the Dengue virus arriving site. In consequence these cells
may be physiologically relevant for in vivo infection when
inoculation occurs by any virus-bearing tick or mosquito.
In this article we have shown that fresh human fibroblasts
obtained from the healthy skin explants are permissive to DENV
infection. These data were generated after double staining with
markers for fibroblasts and DENV. This experimental model was
used to more closely approximate an in vivo infection. Based on
these data, we established human primary dermal fibroblasts
cultures with a reduced number of passages, and we clearly
demonstrated productive infection in all of primary cultures. Thus,
healthy human skin fibroblasts are likely to be involved in the
development of innate immune responses to arthropod or thick-
borne viruses rather than being only target cells whose primary
role has been proposed to serve as replication depot.
However it is important to consider that cumulative work raised
using a wide range of models, with different hosts, mosquito
species and arthropod-borne viruses showing that, mosquito saliva
and/or feeding is associated with a potentiation or control,
affecting virus transmission, host susceptibility, viremia and disease
progression impairing the antiviral immune response [45,46].
In contrast in other experimental data, the expression of anti-
dengue effectors molecules in the distal-lateral lobes of A. aegypti
salivary glands has shown to reduce prevalence and mean
intensities of viral infection [47]. Moreover, Thangamani et al.
demonstrated important differences in the activation of immune
response to CHIKV due the route of transmission showing an up-
regulation of TL3 in both uninfected and CHIKV infected
mosquito bites [48]. This data showed contrasting immune
activation in response to CHIKV. However other studies have
shown no effect on arbovirus infection due to mosquito
transmission.
In summary the studies investigating the effects of mosquito
saliva upon the vertebrate immune response remain unclear and
all together may suggest that at high concentrations some salivary
proteins are immmunosuppressive, whereas lower concentrations
of this modulate the immune response [49].
Understanding the potential role of mosquito saliva over the
DENV infected fibroblasts is a point that must be considered in
the future.
Double-stranded RNA is produced during DENV viral
replication. This molecule can be detected by Toll-like receptors
(TLRs) 3 and 7with in the endosomes, while the RNA helicases
detect viral dsRNA in the cytoplasm. It has been described the
possibility that DENV is detected by RIG-I, TLR3 and TLR7
Figure 5. Production of TNFa,H bD2 and HD5 after mock or DENV-infection of primary skin fibroblasts. A) Mean fluorescence intensity
corresponding to the intracellular staning for TNFa expressed by non-infected (NI), recombinant TNF-treated (TNFr), mock-infected (Mock) and DENV-
2 infected (DENV-2) cells from two different primary cultures obtained from different donors. B) Mean fluorescence intensity corresponding to the
intracellular staining for human b defensin (HbD) and C) Human alpha-defensin (HD5) produced by non-infected (NI), Poly I:C transfected (PIC), mock-
infected (Mock) and DENV-2 infected (DENV-2) cells.
doi:10.1371/journal.pntd.0001420.g005
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transcription factor IRF3 on non-infected fibroblasts (NI), mock-infected fibroblasts (Mock) and infected fibroblasts (DENV-2) at 24 h post infection. B)
Cells were fixed at different times post-infection and assayed for IRF3 localization by immunofluorescence. The cell nuclei were counterstained and
the percentage of cells that microscopically showed an IRF3 increment in the nucleus area at 6, 12, 24, 36, and 48 h post infection were counted. C)
Detection of activation of IRF3 in skin fibroblasts, they were stained with an antibody against active associated phosphorylation (SER 396) and double
stained with an antibody against non-structural protein 3 (NS3) for mock-infected (Mock) and 5-MOI, DENV-2 infected cells. D) Localization of the
transcription factor IRF7 in non-infected fibroblasts (NI), mock-infected fibroblasts (Mock) and infected fibroblasts (DENV-2) at 24 h post-infection. E)
Percentage of cells that showed an IRF7 increment in the nucleus area at 6, 12, 24, 36, and 48 h post-infection. F) Localization of p50 in fibroblasts
infected with DENV. Skin primary fibroblasts were infected at 5 MOI and 48 hours post-infection immunofluorescence was performed for the
localization of p50 NFkB subunit (green) and NS3 (red).
doi:10.1371/journal.pntd.0001420.g006
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[16,18,19,21–23]. These detection systems are not mutually
exclusive and the expression of the PRRs depends on the cell
lineage or origin.
Our data showed that in the primary skin fibroblasts, both
TLR3 and RIG-1 (but not Mda5) molecules are up-regulated at
different times suggesting that both molecules may trigger a
coordinate induction of the antiviral response against DENV.
TLR3 may ‘‘prime’’ the early response while RIG-I might regulate
the amplified response at later time points. This concerted
response has been observed in a model of MEFs infected with
WNV, in which RIG-I mediated the initial detection of WNV
infection in cells of non-immune origin. But RIG-I-deficient cells
were still capable of responding to WNV, suggesting that other
PRRs are also involved in mediating the innate antiviral response.
During DENV detection by skin fibroblasts, none of the
established cultures showed mRNA for TLR7 after DENV
infection. These data may suggest the absence of these PRRs in
such cells. Similarly, Paladino et al. analyzed the TLR expression
in virally infected fibroblasts of different origins and found absence
of TLR7 [10].
The differences in the molecules involved in DENV detection
suggest a differential cytokine profile that may contribute and
maintain the microenvironment collaborating with dendritic cells
(DCs) and possibly other resident cells when the virus arrives. The
activation of the resident DCs depends on viral replication itself and
also on the presence of important mediators such as IFNb,T N F a
and defensins, and they may be modulated by activation of other
signaling pathways,suchastheproduction of double-stranded RNA.
During viral infection various cytokines play a role both in viral
clearance and in tissue damage mechanisms. The type I
interferon’s (IFNs) is regulated by a large family of multifunctional
immunoregulatory proteins such as IRF3 and IRF7. IRF3
possesses a restricted DNA binding site specificity and interacts
with CBP, while IRF-7 has a broader DNA binding specificity that
contributes to its capacity to stimulate IFNa subtype expression.
Both IRF3 and IRF7 play distinct and essential roles in the IFNa/
b response to eliminate the viral infection. At the same time the
activation of transcription factors during the infection depends on
the signal given to the PRRs. Here we observed activation of
IRF3, and we also observed that even if the secretion of IFNb
maintains the temporal kinetics, the magnitude of the response
varies between donors. Moreover, studying skin samples from
different donors, races and ages, would give valuable information
of the innate immune system profile that may correlate with the
susceptibilities of some hosts.
On other hand if the skin fibroblasts produces type I interferons
this event becomes very important in terms of contribution to an
antiviral state, in the infection site, more when considering that
DENV is a strong inducer of type I IFN responses.
The production of defensins by the infected fibroblasts may
increase the recruitment of immune cells such as neutrophils and
monocytes during the DEN infection; otherwise these molecules
may act directly causing virolisis.
Figure 7. DENV-2 infection induced DNA fragmentation in skin primary fibroblasts. Skin fibroblasts were infected with 5 MOIs of DENV-2
or mock infected, and then fixed and stained with mouse anti-NS3 protein (green) followed by FITC-conjugate anti-mouse and then TUNEL (red)
reaction was performed. Apoptosis of DENV-infected skin fibroblasts cells were evaluated at 24 and 48 hr post-infection by epifluorescence
microscopy. Representative staininings of infected and mock-infected cells at 24 hours post- infection.
doi:10.1371/journal.pntd.0001420.g007
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potential activity of human defensins over the viral particle
suggests a direct activity against DENV (unpublished data).
RIG-I activation induces the association with IPS-1 (Cardiff,
Visa or MAVS). This interaction induces the activation of the
inflammatory/antiviral response. However, the exposure of the
Caspase recruitment domains (CARD) of RIG-I and IPS-1 may
also recruit TRADD, RIP-1 and FADD, a molecular complex
known as the TRADDosome, which induces the activation of
caspases 8 and 10 provoking cell death [39]. We detected cell
death early during the infection with DENV (Figure 7) and an
increment of the RIG-I protein (Figure 3D). The apoptosis
activation may be caused by the activation of the innate immune
system; however, more extensive studies are needed to test this
hypothesis. These data corroborate findings previous findings by
our group [50].
Clearly most studies addressing innate immunity in Dengue
have been performed using human or mouse cell lines; however,
not enough work has been performed by using primary human
cultures of cells from the natural host and from the first anatomical
site in contact with DENV when it enters through the natural
route. These cells produce soluble mediators such as IFNs, TNFa
and defensins. The magnitude and the variety of this response will
depend on the amount of virus load inoculated and in
consequence it might limit the infection in situ. Some studies
suggest that the localization of the fibroblasts may confer different
phenotype and gene expression. [51,52] However we used healthy
skin obtained from arm, abdomen and leg among others, and no
differences in terms of permissively to DENV infection were
detected.
Whether the mediators produced by dermal fibroblasts
contribute mainly to pro-inflammatory anti-viral responses, or
whether these cells might be used as in vivo reservoirs where an
initial DENV replication occurs, is still uncertain and deserves
further scrutiny.
As far as we know this is the first study where primary skin
fibroblast cultures from different individuals have been evaluated
for their susceptibility to DENV infection and for the elements of
innate immunity that may contribute to DENV antiviral state.
Moreover, this is the first report showing that defensins may be up-
regulated by skin cells in response to DENV infection.
Supporting Information
Figure S1 Establishment and characterization of skin
fibroblast cultures. A) Details from ten donors with the
corresponding percentages of infection. B) Once the cultures
where established they were characterized with an antibody
against fibroblast protein (IB10) by flow cytometry to assess the
homogeneity of the culture. C) Expression of E glycoprotein in the
skin donors detected by cytometry by using an anti- E monoclonal
antibody.
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